Cubist Pharmaceuticals (United States)
Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cubist Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2022. Read More.
Open Access Percentage
46%
Total
Publications
522
Total Open
Publications
239
Total
Citations
32K
Open Access
Percentage
46%
Total
Publications
522
Total Open
Publications
239
Total
Citations
32K
Breakdown
Publisher Open
17%
Both
17%
Other Platform Open
12%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 17%
30
Hybrid 18%
33
No Guarantees 65%
115
Other Platform Open
Domain 93%
142
Institution 17%
26
Public 9%
14
Other Internet 5%
8
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 142 |
Europe PMC | Domain | 135 |
Semantic Scholar | Public | 13 |
CiteSeer X | Other Internet | 9 |
University College London - UCL Discovery | Institution | 8 |
University of Michigan - Deep Blue | Institution | 4 |
University of Waterloo - UWSpace | Institution | 3 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 3 |
whiterose.ac.uk OAI-PMH Repository | Institution | 2 |
University of Melbourne - Minerva Access | Institution | 2 |